Sanyou Bio and FatiAbGen Forge AI-STAL Alliance for Korea and Global Markets
CompanyDeals

Sanyou Bio and FatiAbGen Forge AI-STAL Alliance for Korea and Global Markets

Ascletis Pharma Advances ASC37 Oral Triple Agonist for Obesity, Targets Q2 2026 FDA IND
CompanyDrug

Ascletis Pharma Advances ASC37 Oral Triple Agonist for Obesity, Targets Q2 2026 FDA IND

Mabwell's 9MW1911 Cuts COPD Exacerbations by 30% in Phase 2a, FDA Accepts US Trial Application
CompanyDrug

Mabwell’s 9MW1911 Cuts COPD Exacerbations by 30% in Phase 2a, FDA Accepts US Trial Application

Imugene and JW Therapeutics Partner to Evaluate onCARlytics CAR‑T Combination for Advanced Solid Tumors
CompanyDeals

Imugene and JW Therapeutics Partner to Evaluate onCARlytics CAR‑T Combination for Advanced Solid Tumors

Humanwell Launches RMB250M Ruicheng Venture Fund for Health Tech
CompanyDeals

Humanwell Launches RMB250M Ruicheng Venture Fund for Health Tech

iRegene's NouvNeu004 Wins FDA Special Exemption for MSA Cell Therapy
CompanyDrug

iRegene’s NouvNeu004 Wins FDA Special Exemption for MSA Cell Therapy

Proviva's PTX-912 PD-1 IL-2 Fusion Gets USD 30M Series A+ Boost
CompanyDeals

Proviva’s PTX-912 PD-1 IL-2 Fusion Gets USD 30M Series A+ Boost

Pfizer-Astellas' PADCEV Wins FDA Approval for Perioperative Bladder Cancer
CompanyDrug

Pfizer-Astellas’ PADCEV Wins FDA Approval for Perioperative Bladder Cancer

GenSci's GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials
CompanyDrug

GenSci’s GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR
CompanyDrug

Jiuzhou Pharmaceutical Wins Tentative FDA Approval for Generic Janumet XR

Hengrui's Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials
CompanyDrug

Hengrui’s Ivarmacitinib Wins NMPA Nod for Vitiligo Clinical Trials

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise
CompanyDrug

Juventas CAR-T Wins Second China Approval for Lymphoma, Expands Hematology Franchise